BFRI Latest Press Releases

-- September 14, 2026 --

Biofrontera Announces FDA Approval of Ameluz Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma Globe Newswire 9:26 AM

-- August 13, 2026 --

Biofrontera Inc. Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth Globe Newswire 8:51 AM

-- August 5, 2026 --

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026 Globe Newswire 4:15 PM

-- May 21, 2026 --

Biofrontera Inc. to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 Globe Newswire 9:15 AM

-- May 14, 2026 --

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update Globe Newswire 7:30 AM

-- May 13, 2026 --

Biofrontera Launches Second Annual "Hats On" Campaign to Raise Awareness of Actinic Keratosis Globe Newswire 9:00 AM

-- May 8, 2026 --

Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 Globe Newswire 4:00 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software